WeightWatchers to buy Sequence telehealth, enter obesity drug prescription business

Canada News News

WeightWatchers to buy Sequence telehealth, enter obesity drug prescription business
Canada Latest News,Canada Headlines
  • 📰 YahooNews
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 59%

WeightWatchers expects the acquisition to complement its nutrition and behavior-change program at a time when obesity drugs are one of the biggest markets. WeightWatchers gets into the obesity drug Rx game and will soon acquire Sequence telehealth:

March 6 - WW International Inc, known as WeightWatchers, said on Monday it is acquiring subscription telehealth platform Sequence, moving the weight-loss program operator into the obesity drug prescription business.

Launched in 2021, Sequence now serves about 24,000 members across the U.S., as of February 2023, and clocks about $25 million in annual revenue on a run-rate basis.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

YahooNews /  🏆 380. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

WeightWatchers is acquiring Sequence for $106 millionWeightWatchers is buying a company that lets you pay $99 a month to see a doctor on video and get a prescription to popular weight-loss drug Ozempic
Read more »

WSJ News Exclusive | WeightWatchers Moves Into the Ozempic Market With Telehealth DealWSJ News Exclusive | WeightWatchers Moves Into the Ozempic Market With Telehealth DealThe weight-management company is buying digital health company Sequence, which offers telehealth visits with doctors.
Read more »

WeightWatchers Bets on So-Called Miracle Obesity Drug Ozempic in New Deal: ReportWeightWatchers Bets on So-Called Miracle Obesity Drug Ozempic in New Deal: ReportThe Wall Street Journal reported Monday that WeightWatchers is buying a telehealth subscription service called Sequence, which allows doctors to prescribe both Ozempic and its sister drug, Wegovy.
Read more »

WeightWatchers Moves Into the Ozempic Market With Telehealth DealWeightWatchers Moves Into the Ozempic Market With Telehealth DealThe weight-management company is buying digital health company Sequence, which offers telehealth visits with doctors.
Read more »

WeightWatchers gets into prescription weight loss businessWeightWatchers gets into prescription weight loss businessWith the acquisition of Sequence, the company is tapping into a red-hot market for prescription drugs that address obesity, and broadening what it offers to customers.
Read more »

WeightWatchers jumps into the prescription weight loss drug business | CNN BusinessWeightWatchers jumps into the prescription weight loss drug business | CNN BusinessWeightWatchers is getting into the booming prescription weight loss drug business.
Read more »



Render Time: 2025-02-27 07:28:00